LAZARD ASSET MANAGEMENT LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 52 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$37,809,000
+15.6%
37,786,000
+16.3%
0.04%
+8.1%
Q3 2021$32,717,000
-10.0%
32,500,000
-11.0%
0.04%
-9.8%
Q2 2021$36,347,000
-10.6%
36,500,000
-6.4%
0.04%
-16.3%
Q1 2021$40,659,000
+137.7%
39,000,000
+116.3%
0.05%
+122.7%
Q4 2020$17,102,000
-10.1%
18,031,000
-13.8%
0.02%
-18.5%
Q3 2020$19,030,000
+11.4%
20,928,000
+6.0%
0.03%
+12.5%
Q4 2019$17,090,000
+20.3%
19,745,000
+16.1%
0.02%
+4.3%
Q3 2019$14,211,000
+64.1%
17,000,000
+70.0%
0.02%
+64.3%
Q2 2019$8,658,00010,000,0000.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Penn Mutual Asset Management 1,214,000$1,164,0001.57%
TFG Asset Management GP Ltd 21,600,000$21,027,0001.44%
TENOR CAPITAL MANAGEMENT Co., L.P. 11,645,000$11,336,0000.26%
OAKTREE CAPITAL MANAGEMENT LP 20,472,000$19,704,0000.23%
PALISADE CAPITAL MANAGEMENT, LP 5,952,000$5,782,0000.16%
SSI INVESTMENT MANAGEMENT LLC 2,000,000$1,916,0000.12%
Cutler Capital Management, LLC 300,000$287,0000.11%
Radcliffe Capital Management, L.P. 3,117,000$2,985,0000.07%
PROSPECTOR PARTNERS LLC 400,000$383,0000.06%
Financial Sense Advisors, Inc. 130,000$125,0000.05%
View complete list of LIGAND PHARMACEUTICALS INC shareholders